Cannara Biotech (TSXV:LOVE) Days Payable : 80.32 (As of Feb. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech Days Payable?

Cannara Biotech's average Accounts Payable for the three months ended in Feb. 2024 was C$13.68 Mil. Cannara Biotech's Cost of Goods Sold for the three months ended in Feb. 2024 was C$15.54 Mil. Hence, Cannara Biotech's Days Payable for the three months ended in Feb. 2024 was 80.32.

The historical rank and industry rank for Cannara Biotech's Days Payable or its related term are showing as below:

TSXV:LOVE' s Days Payable Range Over the Past 10 Years
Min: 114.95 Med: 650.96 Max: 2634.05
Current: 114.95

During the past 6 years, Cannara Biotech's highest Days Payable was 2634.05. The lowest was 114.95. And the median was 650.96.

TSXV:LOVE's Days Payable is ranked better than
63.28% of 975 companies
in the Drug Manufacturers industry
Industry Median: 88.64 vs TSXV:LOVE: 114.95

Cannara Biotech's Days Payable declined from Feb. 2023 (108.59) to Feb. 2024 (80.32). It may suggest that Cannara Biotech accelerated paying its suppliers.

Cannara Biotech Days Payable Historical Data

The historical data trend for Cannara Biotech's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech Days Payable Chart

Cannara Biotech Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Days Payable

Get a 7-Day Free Trial

2,634.05

1,052.78

249.14

153.52

141.20

Cannara Biotech Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Days Payable	Get a 7-Day Free Trial															108.59	159.95	149.10	106.26	80.32

Competitive Comparison of Cannara Biotech's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Cannara Biotech's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannara Biotech's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannara Biotech's Days Payable distribution charts can be found below:

* The bar in red indicates where Cannara Biotech's Days Payable falls into.

Cannara Biotech Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Cannara Biotech's Days Payable for the fiscal year that ended in Aug. 2023 is calculated as

	Days Payable (A: Aug. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Aug. 2022 )	+	Accounts Payable (A: Aug. 2023 ))	/	count )	/	Cost of Goods Sold (A: Aug. 2023 )	*	Days in Period
=	( (9.308	+	13.926)	/	2 )	/	30.029	*	365
=	11.617					/	30.029	*	365
=	141.20

Cannara Biotech's Days Payable for the quarter that ended in Feb. 2024 is calculated as:

	Days Payable (Q: Feb. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Nov. 2023 )	+	Accounts Payable (Q: Feb. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Feb. 2024 )	*	Days in Period
=	( (12.27	+	15.091)	/	2 )	/	15.543	*	365 / 4
=	13.6805					/	15.543	*	365 / 4
=	80.32

Cannara Biotech Days Payable Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannara Biotech (TSXV:LOVE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (TSXV:LOVE) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

LOVFF:USA 8CB0:Germany

Address

1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website

http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .

Executives